0
0
Read Time:12 Second
The U.S. Food and Drug Administration has issued four observations to generic drugmaker Lupin’s biotech facility in Pune. Pre-approval inspection The U.S. FDA conducted a productspecific preapproval inspection at the company’s Pune biotech facility…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %